We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

41 hedge funds and large institutions have $14.2M invested in Gyre Therapeutics in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

24,596% more call options, than puts

Call options by funds: $6.67M | Put options by funds: $27K

122% more capital invested

Capital invested by funds: $6.39M → $14.2M (+$7.81M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.71% less ownership

Funds ownership: 4.11% → 3.4% (-0.71%)

5% less funds holding

Funds holding: 43 → 41 (-2)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

82% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 17

Holders
41
Holders Change
-2
Holders Change %
-4.65%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
3
Reduced
17
Closed
9
Calls
$6.67M
Puts
$27K
Net Calls
+$6.64M
Net Calls Change
+$6.48M

Top Buyers

1
MAP
Madison Avenue Partners
New York
+$892K
2
NCM
Nantahala Capital Management
Connecticut
+$297K
3
Citadel Advisors
Citadel Advisors
Florida
+$67.2K
4
VF
Virtu Financial
New York
+$47.8K
5
Prudential Financial
Prudential Financial
New Jersey
+$18.1K

Top Sellers

1
SM
Sabby Management
Florida
-$871K
2
Renaissance Technologies
Renaissance Technologies
New York
-$330K
3
IC
Ikarian Capital
Texas
-$314K
4
Millennium Management
Millennium Management
New York
-$266K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$100K
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
26
Prudential Financial
New Jersey
$36K +$18.1K +2,720 New
BDF
27
Black Diamond Financial
Maryland
$32K – – –
CCM
28
Colorado Capital Management
Colorado
$24K – – –
UCFA
29
United Capital Financial Advisors
Texas
$18K +$8.86K +1,333 New
Commonwealth Equity Services
30
Commonwealth Equity Services
Massachusetts
$17K – – –
UBS Group
31
UBS Group
Switzerland
$14K +$6.81K +1,024 New
Acadian Asset Management
32
Acadian Asset Management
Massachusetts
$10K -$100K -15,063 -95%
CG
33
Cutler Group
California
$9K – – –
TRCT
34
Tower Research Capital (TRC)
New York
$2K -$1.76K -265 -63%
SPIA
35
Steward Partners Investment Advisory
New York
$2K – – –
Citigroup
36
Citigroup
New York
$1K +$445 +67 New
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$571 -$40 -6 -12%
APA
38
American Portfolios Advisors
New York
$383 – – –
SM
39
Sabby Management
Florida
– -$871K -176,000 Closed
IC
40
Ikarian Capital
Texas
– -$314K -63,550 Closed
CL
41
CSS LLC
Illinois
– -$59K -11,821 Closed
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
– -$51K -10,284 Closed
Two Sigma Investments
43
Two Sigma Investments
New York
– -$41K -8,364 Closed
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
– -$41K -8,316 Closed
BFM
45
Boothbay Fund Management
New York
– -$30K -6,122 Closed
GTCM
46
Gyon Technologies Capital Management
New Jersey
– -$15K -3,123 Closed
GWM
47
Geneos Wealth Management
Colorado
– -$7K -1,467 Closed
JP Morgan Chase
48
JP Morgan Chase
New York
– -$2.69K -404 -98%
Wells Fargo
49
Wells Fargo
California
– -$253 -38 -59%
1
2

GYRE Hedge Fund Activity: Q2 2022 in Review

41 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q2 2022, worth a combined $14.2M — up 122% from $6.39M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of GYRE and 7 opened new positions — a net loss of 2 holders — while 17 trimmed existing stakes and 3 added.

The largest buyer was Madison Avenue Partners, opening a new position worth an estimated $892K. The largest seller was Sabby Management, exiting entirely with an estimated $871K sold.

  • 41 institutional investors held Gyre Therapeutics (GYRE) as of Q2 2022, down from 43 in Q1 2022.
  • Funds reported $14.2M of Gyre Therapeutics stock for Q2 2022, up 122% quarter-over-quarter.
  • 7 funds opened new Gyre Therapeutics positions in Q2 2022 and 9 closed out, a net change of -2 holders.
  • The largest Gyre Therapeutics buyer in Q2 2022 was Madison Avenue Partners, an estimated $892K added.
  • The largest Gyre Therapeutics seller in Q2 2022 was Sabby Management, an estimated $871K sold.

Based on aggregated 13F filings for Q2 2022.